InflaRx (IFRX) Shares Outstanding (Entity) (2017 - 2025)
InflaRx (IFRX) Shares Outstanding (Entity) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.73 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 252.88 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 218.28 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 575.47 Mn |
| 10 | InflaRx | 140.30 Mn | -43.96 Mn | 2.74 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.68 Bn |
| Jun 30, 2025 | 1.69 Bn |
| Dec 31, 2024 | 1.47 Bn |
| Jun 30, 2024 | 1.47 Bn |
| Dec 31, 2023 | 1.37 Bn |
| Jun 30, 2023 | 1.42 Bn |
| Dec 31, 2022 | 1.11 Bn |
| Jun 30, 2022 | 1.11 Bn |
| Dec 31, 2021 | 1.04 Bn |
| Jun 30, 2021 | 1.47 Bn |
| Dec 31, 2020 | 902.16 Mn |
| Dec 31, 2019 | 866.82 Mn |
| Jun 30, 2019 | 865.48 Mn |
| Dec 31, 2018 | 865.48 Mn |
| Sep 30, 2018 | 855.40 Mn |
| Jun 30, 2018 | 855.40 Mn |
| Dec 31, 2017 | 793.74 Mn |
| Sep 30, 2017 | 78.77 Mn |